Title |
Role of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPD
|
---|---|
Published in |
International Journal of Chronic Obstructive Pulmonary Disease, April 2015
|
DOI | 10.2147/copd.s80656 |
Pubmed ID | |
Authors |
Jinming Gao, Roy A Pleasants |
Abstract |
Chronic obstructive pulmonary disease (COPD) and asthma are common airway disorders characterized by chronic airway inflammation and airflow obstruction, and are a leading cause of morbidity and mortality in the People's Republic of China. These two diseases pose a high economic burden on the family and the whole of society. Despite evidence-based Global Initiative for Chronic Obstructive Lung Disease and Global Initiative for Asthma guidelines being available for the diagnosis and management of COPD and asthma, many of these patients are not properly diagnosed or managed in the People's Republic of China. The value of combination therapy with inhaled corticosteroids and long-acting β2-agonists has been established in the management of asthma and COPD globally. Combinations of inhaled corticosteroids and long-acting β2-agonists such as fluticasone and salmeterol, have been shown to be effective for improving symptoms, health status, and reducing exacerbations in both diseases. In this review, we discuss the efficacy and safety of this combination therapy from key studies, particularly in the People's Republic of China. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 2% |
Unknown | 46 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 11 | 23% |
Student > Bachelor | 9 | 19% |
Other | 3 | 6% |
Student > Doctoral Student | 3 | 6% |
Researcher | 3 | 6% |
Other | 7 | 15% |
Unknown | 11 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 19 | 40% |
Pharmacology, Toxicology and Pharmaceutical Science | 8 | 17% |
Nursing and Health Professions | 5 | 11% |
Biochemistry, Genetics and Molecular Biology | 2 | 4% |
Economics, Econometrics and Finance | 1 | 2% |
Other | 1 | 2% |
Unknown | 11 | 23% |